Patricia Ann Duffy

Array ( [id] => 6031006 [patent_doc_number] => 20110081351 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-07 [patent_title] => 'ANTIHUMAN BAFF ANTIBODY' [patent_app_type] => utility [patent_app_number] => 12/891327 [patent_app_country] => US [patent_app_date] => 2010-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5902 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20110081351.pdf [firstpage_image] =>[orig_patent_app_number] => 12891327 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10870526 [patent_doc_number] => 08895724 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-25 [patent_title] => 'Multivalent pneumococcal polysaccharide-protein conjugate composition' [patent_app_type] => utility [patent_app_number] => 12/887636 [patent_app_country] => US [patent_app_date] => 2010-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 18362 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12887636 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11303752 [patent_doc_number] => 09511133 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-12-06 [patent_title] => 'Vaccine against cholera and enterotoxigenic E. coli (ETEC) diarrhea' [patent_app_type] => utility [patent_app_number] => 13/496183 [patent_app_country] => US [patent_app_date] => 2010-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8252 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13496183 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4608589 [patent_doc_number] => 07993844 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2011-08-09 [patent_title] => 'Artificial chimeras engineered to simulate multiple biological threat agents' [patent_app_type] => utility [patent_app_number] => 12/873825 [patent_app_country] => US [patent_app_date] => 2010-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5083 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/993/07993844.pdf [firstpage_image] =>[orig_patent_app_number] => 12873825 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4639303 [patent_doc_number] => 08017330 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2011-09-13 [patent_title] => 'Artificial chimeras engineered to simulate multiple biological threat agents' [patent_app_type] => utility [patent_app_number] => 12/873777 [patent_app_country] => US [patent_app_date] => 2010-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5127 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/017/08017330.pdf [firstpage_image] =>[orig_patent_app_number] => 12873777 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4513648 [patent_doc_number] => 07910365 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2011-03-22 [patent_title] => 'Artificial chimeras engineered to simulate multiple biological threat agents' [patent_app_type] => utility [patent_app_number] => 12/872851 [patent_app_country] => US [patent_app_date] => 2010-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5130 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/910/07910365.pdf [firstpage_image] =>[orig_patent_app_number] => 12872851 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8335143 [patent_doc_number] => 20120201853 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-09 [patent_title] => 'USE OF A HOLOTOXIN TO REDUCE ENDOPLASMIC RETICULUM-ASSOCIATED DEGRADATION OF MISFOLDED PROTEINS' [patent_app_type] => utility [patent_app_number] => 13/393082 [patent_app_country] => US [patent_app_date] => 2010-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3944 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13393082 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5958540 [patent_doc_number] => 20110182927 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-28 [patent_title] => 'Inhibitors of DNA Immunostimulatory Sequence Activity' [patent_app_type] => utility [patent_app_number] => 12/862429 [patent_app_country] => US [patent_app_date] => 2010-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9564 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20110182927.pdf [firstpage_image] =>[orig_patent_app_number] => 12862429 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9344797 [patent_doc_number] => 08663944 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-04 [patent_title] => 'Cartilage intermediate layer protein 2 C1 and its use to differentiate osteoarthritis from rheumatoid arthritis and non-disease conditions' [patent_app_type] => utility [patent_app_number] => 12/806590 [patent_app_country] => US [patent_app_date] => 2010-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4993 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 147 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12806590 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6054551 [patent_doc_number] => 20110110911 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'Methods of Treating Cancer Using Tachykinin Retargeted Endopepidases' [patent_app_type] => utility [patent_app_number] => 12/856996 [patent_app_country] => US [patent_app_date] => 2010-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 63995 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20110110911.pdf [firstpage_image] =>[orig_patent_app_number] => 12856996 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5975826 [patent_doc_number] => 20110070211 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-24 [patent_title] => 'Methods of Treating Cancer Using Galanin Retargeted Endopepidases' [patent_app_type] => utility [patent_app_number] => 12/856285 [patent_app_country] => US [patent_app_date] => 2010-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 63706 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20110070211.pdf [firstpage_image] =>[orig_patent_app_number] => 12856285 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6201927 [patent_doc_number] => 20110064713 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-17 [patent_title] => 'Methods of Treating Cancer Using Opioid Retargeted Endopepidases' [patent_app_type] => utility [patent_app_number] => 12/855962 [patent_app_country] => US [patent_app_date] => 2010-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 63252 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20110064713.pdf [firstpage_image] =>[orig_patent_app_number] => 12855962 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8323497 [patent_doc_number] => 20120195907 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-02 [patent_title] => 'MONOCLONAL ANTIBODIES AGAINST THE PBP2-A PROTEIN AND HOMOLOGOUS SEQUENCES FOR THE TREATMENT OF INFECTIONS BY AND IMMUNODIAGNOSTICS OF BACTERIA OF THE FIRMICUTES PHYLUM' [patent_app_type] => utility [patent_app_number] => 13/389860 [patent_app_country] => US [patent_app_date] => 2010-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12487 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13389860 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7729223 [patent_doc_number] => 08101406 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-24 [patent_title] => 'Protective anti-glucan antibodies with preference for β-1,3-glucans' [patent_app_type] => utility [patent_app_number] => 12/851962 [patent_app_country] => US [patent_app_date] => 2010-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 13 [patent_no_of_words] => 10288 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/101/08101406.pdf [firstpage_image] =>[orig_patent_app_number] => 12851962 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6142145 [patent_doc_number] => 20110129460 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-02 [patent_title] => 'Combination Antibodies For The Treatment And Prevention Of Disease Caused By Bacillus Anthracis And Related Bacteria And Their Toxins' [patent_app_type] => utility [patent_app_number] => 12/840779 [patent_app_country] => US [patent_app_date] => 2010-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 26547 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20110129460.pdf [firstpage_image] =>[orig_patent_app_number] => 12840779 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5992583 [patent_doc_number] => 20110014236 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-20 [patent_title] => 'NOVEL PROTEIN CAPABLE OF INHIBITING ANTHRAX TOXIN ACTIVITY' [patent_app_type] => utility [patent_app_number] => 12/839383 [patent_app_country] => US [patent_app_date] => 2010-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 4206 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20110014236.pdf [firstpage_image] =>[orig_patent_app_number] => 12839383 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8346849 [patent_doc_number] => 20120207777 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-16 [patent_title] => 'DETOXIFIED ESCHERICHIA COLI IMMUNOGENS' [patent_app_type] => utility [patent_app_number] => 13/384224 [patent_app_country] => US [patent_app_date] => 2010-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 25091 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13384224 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10635665 [patent_doc_number] => 09353160 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-05-31 [patent_title] => 'Method of prophlactically treating infection using a recombinant fibrinogen binding protein clumping factor A (ClfA) or fragment thereof' [patent_app_type] => utility [patent_app_number] => 13/384234 [patent_app_country] => US [patent_app_date] => 2010-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 15121 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 210 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13384234 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16786099 [patent_doc_number] => 10988511 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-04-27 [patent_title] => Conserved [patent_app_type] => utility [patent_app_number] => 13/382906 [patent_app_country] => US [patent_app_date] => 2010-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 29899 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13382906 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6265008 [patent_doc_number] => 20100297677 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'CYCOCHROME C SYNTHESIS INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/831643 [patent_app_country] => US [patent_app_date] => 2010-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 16944 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20100297677.pdf [firstpage_image] =>[orig_patent_app_number] => 12831643 [rel_patent_id] =>[rel_patent_doc_number] =>)